saic-8k_20141231.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

______________

FORM 11-K

______________

x

ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the fiscal year ended December 31, 2014

¨

TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                to               

Commission file number: 001-35832

______________

A. Full title of plan and the address of the plan, if different from that of the issuer named below:

Science Applications International Corporation Retirement Plan

B. Name of issuer of the securities held pursuant to the plan and the address of its principal executive office:

Science Applications International Corporation

1710 SAIC Drive

McLean, VA 22102

 

 

 

 

 


 

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION RETIREMENT PLAN

TABLE OF CONTENTS

 

 

 

Page

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

1

 

 

 

FINANCIAL STATEMENTS AS OF DECEMBER 31, 2014 AND 2013 AND FOR THE YEAR ENDED DECEMBER 31, 2014 AND FOR THE PERIOD FROM SEPTEMBER 28, 2013 TO DECEMBER 31, 2013:

 

 

Statements of Net Assets Available for Benefits

 

2

Statements of Changes in Net Assets Available for Benefits

 

3

Notes to Financial Statements

 

4-8

 

 

 

SUPPLEMENTAL SCHEDULE AS OF DECEMBER 31, 2014:

 

 

Form 5500, Schedule H, Part IV, Line 4i—Schedule of Assets (Held at End of Year)

 

9

 

 

 

SIGNATURE

 

10

 

 

 

EXHIBIT INDEX

 

11

 

NOTE: All other schedules required by Section 29 CFR 2520.103-10 of the Department of Labors Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974 have been omitted because they are not applicable.

 

 

 

 

 


 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Benefit Plans Committee and Participants of

Science Applications International Corporation Retirement Plan

McLean, Virginia

We have audited the accompanying statements of net assets available for benefits of Science Applications International Corporation Retirement Plan (the Plan) as of December 31, 2014 and 2013 and the related statements of changes in net assets available for benefits for the year ended December 31, 2014 and the period from September 27, 2013 (inception) to December 31, 2013. These financial statements are the responsibility of the Plan’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Plan is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Plan’s internal control over financial reporting. Accordingly, we express no such opinion. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the net assets available for benefits of the Plan as of December 31, 2014 and 2013, and the changes in net assets available for benefits for the year and period then ended, respectively, in conformity with accounting principles generally accepted in the United States of America.

The supplemental information in the accompanying schedule of assets (held at end of year) as of December 31, 2014, has been subjected to audit procedures performed in conjunction with the audit of the Plan’s financial statements. The supplemental information is presented for the purpose of additional analysis and is not a required part of the financial statements but includes supplemental information required by the Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. The supplemental information is the responsibility of the Plan’s management. Our audit procedures included determining whether the supplemental information reconciles to the financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the supplemental information. In forming our opinion on the supplemental information in the accompanying schedule, we have evaluated whether the supplemental information, including its form and content, is presented in conformity with the Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. In our opinion, the supplemental information is fairly stated in all material respects in relation to the basic financial statements taken as a whole.

/s/ MAYER HOFFMAN MCCANN P.C.

San Diego, California

June 26, 2015

1

 


 

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION RETIREMENT PLAN

STATEMENTS OF NET ASSETS AVAILABLE FOR BENEFITS

AS OF DECEMBER 31, 2014 AND 2013 (in thousands)

 

 

 

 

2014

 

 

 

2013

 

ASSETS:

 

 

 

 

 

 

 

 

Investments—at fair value:

 

 

 

 

 

 

 

 

Mutual funds

 

$

967,087

 

 

$

877,651

 

Science Applications International Corporation common stock

 

 

58,720

 

 

 

36,214

 

Leidos Holdings, Inc. common stock

 

 

 

 

 

76,577

 

Common collective trusts

 

 

594,601

 

 

 

496,077

 

Total investments

 

 

1,620,408

 

 

 

1,486,519

 

Receivables:

 

 

 

 

 

 

 

 

Notes receivable from participants

 

 

24,129

 

 

 

28,766

 

Employer contributions

 

 

1,183

 

 

 

1,424

 

Participant contributions

 

 

1

 

 

 

1

 

Total receivables

 

 

25,313

 

 

 

30,191

 

NET ASSETS AVAILABLE FOR BENEFITS

 

$

1,645,721

 

 

$

1,516,710

 

 

See notes to financial statements.

 

2

 


 

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION RETIREMENT PLAN

STATEMENTS OF CHANGES IN NET ASSETS AVAILABLE FOR BENEFITS

FOR THE YEAR ENDED DECEMBER 31, 2014 AND FOR THE PERIOD FROM SEPTEMBER 28, 2013 TO

DECEMBER 31, 2013 (in thousands)

 

 

 

 

2014

 

 

 

2013

 

ADDITIONS:

 

 

 

 

 

 

 

 

Investment income:

 

 

 

 

 

 

 

 

Net appreciation in fair value of investments

 

$

78,287

 

 

$

58,782

 

Interest and dividends

 

 

36,490

 

 

 

16,368

 

Total investment income

 

 

114,777

 

 

 

75,150

 

Interest income on notes receivable from participants

 

 

1,123

 

 

 

276

 

Total income

 

 

115,900

 

 

 

75,426

 

Contributions:

 

 

 

 

 

 

 

 

Participants

 

 

86,466

 

 

 

16,122

 

Employer

 

 

33,519

 

 

 

11,359

 

Participant rollovers

 

 

14,159

 

 

 

2,035

 

Total contributions

 

 

134,144

 

 

 

29,516

 

Total additions

 

 

250,044

 

 

 

104,942

 

DEDUCTIONS:

 

 

 

 

 

 

 

 

Distributions paid to participants

 

 

120,391

 

 

 

18,524

 

Administrative expenses

 

 

946

 

 

 

180

 

Total deductions

 

 

121,337

 

 

 

18,704

 

INCREASE IN NET ASSETS AVAILABLE FOR BENEFITS

 

 

128,707

 

 

 

86,238

 

TRANSFER FROM OTHER PLAN

 

 

304

 

 

 

1,430,472

 

NET ASSETS AVAILABLE FOR BENEFITS

 

 

 

 

 

 

 

 

Beginning of period

 

 

1,516,710

 

 

 

 

End of period

 

$

1,645,721

 

 

$

1,516,710

 

 

See notes to financial statements.

 

 

 

3

 


SCIENCE APPLICATIONS INTERNATIONAL CORPORATION RETIREMENT PLAN

NOTES TO FINANCIAL STATEMENTS

AS OF DECEMBER 31, 2014 AND 2013 AND FOR THE YEAR ENDED DECEMBER 31, 2014

AND FOR THE PERIOD FROM SEPTEMBER 28, 2013 TO DECEMBER 31, 2013

 

1. DESCRIPTION OF THE PLAN

The following brief description of the Science Applications International Corporation Retirement Plan (the “Plan”) is for general information purposes only. Participants should refer to the Plan document and the Summary Plan Description for complete information regarding the Plan. Within these financial statements, Science Applications International Corporation (the “Company”) refers to the sponsoring employer. Effective September 27, 2013, the board of directors approved the separation of SAIC, Inc. into two separate, independent, publicly-traded companies: Science Applications International Corporation and Leidos Holdings, Inc. (the “Separation”). The period from September 28, 2013 to December 31, 2013 is the prior Plan year. Effective with the Separation, the Company made no material modifications to the Plan’s operations and mirrored the legacy plan until January 1, 2014, at which time amendments were made to the provisions regarding employer contributions and vesting (see Employer Contributions and Vesting and Forfeitures below).

General—The Plan is a defined contribution plan sponsored by the Company and is subject to the provisions of the Employee Retirement Income Security Act of 1974, as amended (ERISA). The Plan is a defined contribution 401(k) plan with profit-sharing and employee stock ownership plan (ESOP) features. Both employee and Company contributions to the Plan are held in a qualified retirement trust fund. The Science Applications International Corporation Benefit Plans Committee is the Plan’s named fiduciary for purposes of Section 402(a) of ERISA.

Investment Funds—As of December 31, 2014, the Plan held investments in 14 mutual funds, 15 common collective trust funds, and 2 Company stock funds: the SAIC Common Stock Fund and the SAIC Closed Stock Fund (collectively, the “Stock Funds”). Because of the Separation there were 2 other common stock funds as of December 31, 2013: The Leidos Holdings, Inc. Common Stock Fund and the Leidos Holdings, Inc. Closed Stock Fund, which were discontinued in December 2014.

As of December 31, 2014, all amounts in the Stock Funds are invested in Science Applications International Corporation common stock, except for estimated cash reserves, which are invested in the Vanguard Prime Money Market Fund and are primarily used to provide future benefit distributions and facilitate investment exchanges.

Eligibility—Employees of the Company are eligible to participate in the Plan. Employees must be in an eligible fringe benefit package to be eligible to receive Company matching 401(k) contributions. Generally, employees may make elective contributions and receive Company matching 401(k) contributions upon commencing employment.

Participant Contributions—The Plan permits participants to contribute up to 75% of their eligible compensation to the Plan, subject to statutory limitations. Participants may also contribute amounts representing rollovers from other qualified plans. Participant contributions are invested according to participant direction into any of the available investment funds of the Plan. Participant contributions and rollovers to the SAIC Common Stock Fund are limited to a maximum 50% of the employee deferral or rollover, as applicable.

Employer Contributions—The Company may make matching 401(k) contributions. Eligible participants may receive Company matching 401(k) contributions based on a percentage (up to a maximum match percentage of 4%), depending on fringe benefit package, which are invested per participant direction. The Company, at its discretion, may also make additional contributions to the Plan for the benefit of non-highly compensated participants in order to comply with Section 401(k) (3) of the Internal Revenue Code; however, the Company made no such additional contributions for the Plan year and period ended December 31, 2014 and 2013, respectively. Company contributions to the Plan for the Plan year and period ended December 31, 2014 and 2013, respectively, were made in cash.

Participant Accounts—In accordance with Plan provisions, individual accounts are maintained for each Plan participant. Each participant’s account is credited with the participant’s contributions, and if eligible, allocations of Company contributions. Allocations are based on participant eligible compensation, as defined in the Plan document. Participant accounts also reflect changes from investment income and losses and from distributions. The benefit to which a participant is entitled is the vested balance of his or her account.

Vesting and Forfeitures—Participants’ elective deferrals, rollover contributions and Company contributions together with associated earnings vest immediately. Amounts forfeited prior to the adoption of the January 1, 2014, Plan amendments were applied primarily toward Company matching 401(k) contributions and amounted to approximately $305,000 and $14,000 for the year and period ended December 31, 2014 and 2013, respectively.

4

 


SCIENCE APPLICATIONS INTERNATIONAL CORPORATION RETIREMENT PLAN

NOTES TO FINANCIAL STATEMENTS

AS OF DECEMBER 31, 2014 AND 2013 AND FOR THE YEAR ENDED DECEMBER 31, 2014

AND FOR THE PERIOD FROM SEPTEMBER 28, 2013 TO DECEMBER 31, 2013

 

Notes Receivable from Participants—Participants may borrow up to 50% of their vested account balance, up to a maximum of $50,000. Loan repayment periods may not exceed 60 months except for loans used to acquire a principal residence, in which case the repayment period may not exceed 30 years. If a participant defaults on a loan, it becomes a deemed distribution from the Plan to the participant. The loans bear interest at a rate commensurate with local prevailing rates as determined monthly by the plan administrator. Principal and interest are collected ratably through payroll deductions. Outstanding loans bear interest at rates ranging from 4.25% to 10%, and have maturities from January 2015 to October 2044.

Distributions to Participants—For vested account balances less than $1,000, participants receive their vested account balance in a single lump sum following termination of employment with the Company. For vested account balances that exceed $1,000, but is less than $5,000, a participant’s vested account balance automatically rolled over into an Individual Retirement Account. For vested account balances that exceed $5,000, balances are not distributed unless the participant elects to take a distribution following the participant’s termination of employment with the Company. Regardless of the existing account balance, distributions are made when participants die or become permanently disabled while employed by the Company. After attaining age 59-1/2, a participant may make withdrawals even if still employed by the Company. A participant may make withdrawals from the Plan prior to attaining age 59-1/2 from their rollover account or if the participant incurs a financial hardship, as specified by the Plan document. Former employees, regardless of their age, may elect to receive up to two distributions in any given Plan year, of all or a portion of their account balance.

Tax Status—The Internal Revenue Service (IRS) has determined and informed the Company by a letter dated February 28, 2014, that the Plan was designed in accordance with the applicable requirements of the Internal Revenue Code. Accordingly, no provision for income taxes has been included in the Plan’s financial statements. Accounting principles generally accepted in the United States of America require Plan management to evaluate tax positions taken by the Plan and recognize a tax liability if the Plan has taken an uncertain position that more likely than not would not be sustained upon examination by the Internal Revenue Service. The Plan is subject to routine audits by taxing jurisdictions; however, there are currently no audits for any tax periods in progress. The Plan’s tax filings for 2014 and 2013 are subject to examination.

Termination of the Plan—Although it has not expressed any intent to do so, the Company has the right under the Plan to discontinue its contributions and to terminate the Plan at any time subject to the provisions of ERISA. Upon termination of the Plan, the participants become 100% vested in any unvested portion of their accounts.

Transfer from Other Plan—In connection with the Separation, the undistributed participant account balances in the Leidos, Inc. Retirement Plan were transferred to the Science Applications International Corporation Retirement Plan (see Note 5 below).

Related-Party Transactions—Certain Plan investments are managed by The Vanguard Group, the Plan’s record-keeper; therefore, transactions with these investments qualify as party-in-interest transactions. Fees paid to the record-keeper were $946,000 and $180,000 for the year and period ended December 31, 2014 and 2013, respectively. There were no amounts payable to the Plan’s record-keeper as of December 31, 2014 and 2013. The Plan’s administrative body members also participate in the Plan.

Science Applications International Corporation is the sponsoring employer as of December 31, 2014 and 2013. Science Applications International Corporation was formed from the Separation described above. At December 31, 2014 and 2013, the following Science Applications International Corporation and Leidos Holdings, Inc. shares were held by the Plan (in thousands):

 

 

 

2014

 

 

2013

 

 

 

Number of Shares

 

 

Cost Basis

 

 

Number of Shares

 

 

Cost Basis

 

Science Applications International Corporation common stock

 

 

1,187

 

 

$

36,694

 

 

 

1,117

 

 

$

30,620

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Leidos Holdings, Inc. common stock

 

 

 

 

 

 

 

 

1,646

 

 

$

54,226

 

 

 

2. SIGNIFICANT ACCOUNTING POLICIES

Basis of Accounting—The Plan’s financial statements are prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America. Investment transactions are accounted for on their trade dates.

Investment Valuation and Income Recognition—Investments held by the Plan are carried at fair value as follows:

Investment in Mutual Funds—The Plan’s investments in mutual funds are stated at fair value based on quoted market prices.

5

 


SCIENCE APPLICATIONS INTERNATIONAL CORPORATION RETIREMENT PLAN

NOTES TO FINANCIAL STATEMENTS

AS OF DECEMBER 31, 2014 AND 2013 AND FOR THE YEAR ENDED DECEMBER 31, 2014

AND FOR THE PERIOD FROM SEPTEMBER 28, 2013 TO DECEMBER 31, 2013

 

Investment in Common Collective Trusts—As of December 31, 2014, the Plan held investments in 15 common collective trusts: a series of Vanguard Target Retirement Trusts; the Wellington Trust Small Cap 2000 Portfolio; the Wellington Trust TIPS Portfolio; and the T. Rowe Price U.S. Mid-Cap Value Equity Trust. Fair value for these investments is determined by the trustee using observable inputs other than unadjusted quoted prices.

Investment in Common Stock—Investments in shares of Science Applications International Corporation common stock, which are publicly traded on the New York Stock Exchange, are recorded at their publicly-traded quoted market price as closing of December 31, 2014 and 2013.

Investment Gains and Losses—Realized gains and losses on sales of investments are calculated as the difference between the fair value of the investments upon sale and the fair value of the investments at purchase. Unrealized appreciation or depreciation is calculated as the difference between the fair value of the investments at the end of the year and the fair value of the investments at the beginning of the year or at purchase if purchased during the year. Interest income is recorded on the accrual basis of accounting. Dividends are recorded on the ex-dividend date.

Notes Receivable from Participants—Notes receivable from participants are carried at the aggregate unpaid principal balance, plus accrued, unpaid interest of loans outstanding.

Benefits Payable—Benefit payments to participants are recorded upon distribution. There were no benefits payable to participants who had elected to withdraw from the Plan but had not yet been paid as of December 31, 2014 and 2013.

Accounting Estimates—The preparation of financial statements in conformity with generally accepted accounting principles requires Plan management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of additions and deductions during the reporting periods. Actual results may differ from those estimates.

Administrative Expenses—Administrative expenses of the Plan are paid by the Plan sponsor or Plan participants as provided in the Plan document.

Accounting Standards Updates Issued But Not Yet Adopted—In May 2015, the Financial Accounting Standards Board issued Accounting Standards Update (ASU) No. 2015-07, Fair Value Measurement (Topic 820)—Disclosures for Investments in Certain Entities That Calculate Net Asset Value per Share (or Its Equivalent). This ASU removes the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using net asset value per share as a practical expedient. The ASU will become effective for the Plan in the year ending December 31, 2016, and earlier adoption is permitted. Management has not adopted this ASU nor determined the potential effects on the Plan’s financial statements.

 

3.INVESTMENT INFORMATION

The Plan’s investments are held in a trust fund. The fair values of the investments each representing 5% or more of the Plan’s net assets available for benefits as of December 31, 2014 and 2013, respectively, are as follows (in thousands):

 

 

 

 

2014

 

 

 

2013

 

Mutual funds:

 

 

 

 

 

 

 

 

Vanguard Institutional Index Fund

 

$

171,127

 

 

$

145,293

 

Dodge & Cox Stock Fund

 

 

111,051

 

 

 

105,201

 

Vanguard Target Retirement 2025 Trust I

 

 

108,031

 

 

*

 

Vanguard Total Bond Market Index Fund Institutional Shares

 

 

104,104

 

 

 

82,456

 

Vanguard Target Retirement 2020 Trust I

 

 

96,789

 

 

*

 

Vanguard Extended Market Index Fund Institutional Shares

 

 

96,325

 

 

 

96,446

 

Vanguard PRIMECAP Fund Admiral Shares

 

 

92,338

 

 

*

 

Vanguard Prime Money Market Fund Institutional Shares

 

 

87,366

 

 

 

85,756

 

Vanguard Target Retirement 2030 Trust I

 

 

86,338

 

 

*

 

Vanguard Target Retirement 2025 Trust II

 

*

 

 

 

85,613

 

Vanguard Target Retirement 2020 Trust II

 

*

 

 

 

79,832

 

Leidos Holdings, Inc. common stock

 

*

 

 

 

76,577

 

 

 

 

 

 

 

 

 

 

* Investment does not represent 5% or more of net assets available for benefits

 

 

 

 

 

 

6

 


SCIENCE APPLICATIONS INTERNATIONAL CORPORATION RETIREMENT PLAN

NOTES TO FINANCIAL STATEMENTS

AS OF DECEMBER 31, 2014 AND 2013 AND FOR THE YEAR ENDED DECEMBER 31, 2014

AND FOR THE PERIOD FROM SEPTEMBER 28, 2013 TO DECEMBER 31, 2013

 

During the year and period ended December 31, 2014 and 2013, respectively, the Plan’s investments (including investments bought, sold, and held during the period) appreciated as follows (in thousands):

 

 

 

 

2014

 

 

 

2013

 

Mutual funds

 

$

32,330

 

 

$

31,921

 

Common collective trusts

 

 

37,016

 

 

 

25,924

 

Common stocks

 

 

8,941

 

 

 

937

 

Net appreciation in fair value

 

$

78,287

 

 

$

58,782

 

 

The Plan invests in various securities, and investment securities, in general, are exposed to various risks, such as interest rate risk, credit risk, and overall market volatility. Due to the level of risk associated with investment securities, it is reasonably possible that changes in the values of certain investment securities will occur in the near term and such changes could materially affect the amounts reported in the statement of net assets available for benefits and statement of changes in net assets available for benefits.

 

4.FAIR VALUE MEASUREMENTS

Accounting guidance has been issued that establishes a framework for measuring fair value. That framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The three levels of the fair value hierarchy are described below:

Level 1

Unadjusted quoted prices for identical assets or liabilities in active markets that the Plan has the ability to access.

Level 2

Inputs to the valuation methodology include: quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in inactive markets; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means. If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability.

Level 3

Inputs to the valuation methodology are unobservable and significant to the fair value measurement.

 

The following table sets forth by level, within the fair value hierarchy, the Plan’s investments at fair value as of December 31, 2014 and 2013 (in thousands):

 

 

 

Level 1

 

 

Level 2

 

 

Total

 

 

 

 

2014

 

 

 

2013

 

 

 

2014

 

 

 

2013

 

 

 

2014

 

 

 

2013

 

Mutual funds:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Domestic equity funds

 

$

571,363

 

 

$

584,976

 

 

$

 

 

$

 

 

$

571,363

 

 

$

584,976

 

Bond funds

 

 

170,481

 

 

 

148,580

 

 

 

 

 

 

 

 

 

170,481

 

 

 

148,580

 

Short term reserve funds

 

 

94,853

 

 

 

91,198

 

 

 

 

 

 

 

 

 

94,853

 

 

 

91,198

 

International equity funds

 

 

130,390

 

 

 

52,897

 

 

 

 

 

 

 

 

 

130,390

 

 

 

52,897

 

Common stock:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Science Applications International Corporation

 

 

58,720

 

 

 

36,214

 

 

 

 

 

 

 

 

 

58,720

 

 

 

36,214

 

Leidos Holdings, Inc.

 

 

 

 

 

76,577

 

 

 

 

 

 

 

 

 

 

 

 

76,577

 

Common collective trusts:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balanced funds

 

 

 

 

 

 

 

 

530,991

 

 

 

435,928

 

 

 

530,991

 

 

 

435,928

 

Domestic equity funds

 

 

 

 

 

 

 

 

57,534

 

 

 

55,354

 

 

 

57,534

 

 

 

55,354

 

Bond funds

 

 

 

 

 

 

 

 

6,076

 

 

 

4,795

 

 

 

6,076

 

 

 

4,795

 

Total investments at fair value

 

$

1,025,807

 

 

$

990,442

 

 

$

594,601

 

 

$

496,077

 

 

$

1,620,408

 

 

$

1,486,519

 

 

The Plan did not have any Level 3 investments as of December 31, 2014 and 2013.

 

7

 


SCIENCE APPLICATIONS INTERNATIONAL CORPORATION RETIREMENT PLAN

NOTES TO FINANCIAL STATEMENTS

AS OF DECEMBER 31, 2014 AND 2013 AND FOR THE YEAR ENDED DECEMBER 31, 2014

AND FOR THE PERIOD FROM SEPTEMBER 28, 2013 TO DECEMBER 31, 2013

5.RECONCILIATION OF FINANCIAL STATEMENTS TO FORM 5500

The following is a reconciliation of net assets available for benefits as of December 31, 2014 and 2013, as reported in the financial statements, to Schedule H on Form 5500 (in thousands):

 

 

 

 

2014

 

 

 

2013

 

Net assets available for benefits as reported in the financial statements

 

$

1,645,721

 

 

$

1,516,710

 

Participant loans deemed distributed

 

 

 

 

 

(564

)

Deemed loans offset or repaid

 

 

 

 

 

26

 

Net assets available for benefits reported on Schedule H of Form 5500

 

$

1,645,721

 

 

$

1,516,172

 

 

The following is a reconciliation of the transfer to the Plan from the legacy plan for the period ended December 31, 2013, as reported in the financial statements, to Schedule H on Form 5500 (in thousands):

 

 

 

 

 

 

 

 

2013

 

Transfer of assets from other plan as reported in the financial statements

 

 

 

 

 

$

1,430,472

 

Loans deemed transferred

 

 

 

 

 

 

(310

)

Transfer of assets from other plan reported on Schedule H of Form 5500

 

 

 

 

 

$

1,430,162

 

 

The following is a reconciliation of deemed distributions of participant loans for the year and period ended December 31, 2014 and 2013, respectively, as reported in the financial statements, to Schedule H on Form 5500 (in thousands):

 

 

 

 

2014

 

 

 

2013

 

Distributions of participant loans as reported in the financial statements

 

$

 

 

$

 

Participant loans deemed distributed

 

 

75

 

 

 

254

 

Deemed distributions of participant loans reported on Schedule H of Form 5500

 

$

75

 

 

$

254

 

 

 

 

 

******

 

8

 


 

SUPPLEMENTAL SCHEDULE

 

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION RETIREMENT PLAN

 

FORM 5500, SCHEDULE H, PART IV, LINE 4i—SCHEDULE OF ASSETS (HELD AT END OF YEAR) AS OF DECEMBER 31, 2014 (in thousands)

 

 

 

 

 

EIN: 30-6419427

 

Plan #001

 

 

 

Identity of Issue, Borrower, Lessor, or Similar Party

 

Description of Investment

Including maturity Date,

Rate of Interest and

Collateral

 

Cost

 

Current Value

 

*

 

Science Applications International Corporation common stock

 

Company Stock

 

**

 

$

58,720

 

*

 

DFA Emerging Markets Core Equity Port: Institutional Shares

 

Mutual Fund

 

**

 

 

26,967

 

*

 

Dodge & Cox Stock Fund

 

Mutual Fund

 

**

 

 

111,051

 

*

 

Longleaf Partners Small-Cap Fund

 

Mutual Fund

 

**

 

 

46,809

 

*

 

PIMCO Total Return Fund; Institutional Class

 

Mutual Fund

 

**

 

 

40,757

 

*

 

T. Rowe Price Institutional Mid Cap Equity Growth Fund

 

Mutual Fund

 

**

 

 

53,713

 

*

 

Vanguard Extended Market Index Fund: Institutional Shares

 

Mutual Fund

 

**

 

 

96,325

 

*

 

Vanguard FTSE All-World ex-US Index Fund Institutional Shares

 

Mutual Fund

 

**

 

 

54,116

 

*

 

Vanguard Federal Money Market Fund

 

Mutual Fund

 

**

 

 

7,487

 

*

 

Vanguard Institutional Index Fund

 

Mutual Fund

 

**

 

 

171,127

 

*

 

Vanguard International Growth Fund Admiral Shares

 

Mutual Fund

 

**

 

 

49,307

 

*

 

Vanguard PRIMECAP Fund Admiral Shares

 

Mutual Fund

 

**

 

 

92,338

 

*

 

Vanguard Prime Money Market Fund Institutional Shares

 

Mutual Fund

 

**

 

 

87,366

 

*

 

Vanguard Short-Term Bond Index Fund Institutional

 

Mutual Fund

 

**

 

 

25,620

 

*

 

Vanguard Total Bond Market Index Fund Institutional Shares

 

Mutual Fund

 

**

 

 

104,104

 

*

 

T. Rowe Price U.S. Mid Cap-Value Equity Trust; D Class

 

Common Collective Trust

 

**

 

 

36,258

 

*

 

Vanguard Target Retirement 2010 Trust I

 

Common Collective Trust

 

**

 

 

20,449

 

*

 

Vanguard Target Retirement 2015 Trust I

 

Common Collective Trust

 

**

 

 

66,638

 

*

 

Vanguard Target Retirement 2020 Trust I

 

Common Collective Trust

 

**

 

 

96,789

 

*

 

Vanguard Target Retirement 2025 Trust I

 

Common Collective Trust

 

**

 

 

108,031

 

*

 

Vanguard Target Retirement 2030 Trust I

 

Common Collective Trust

 

**

 

 

86,338

 

*

 

Vanguard Target Retirement 2035 Trust I

 

Common Collective Trust

 

**

 

 

53,805

 

*

 

Vanguard Target Retirement 2040 Trust I

 

Common Collective Trust

 

**

 

 

36,046

 

*

 

Vanguard Target Retirement 2045 Trust I

 

Common Collective Trust

 

**

 

 

26,393

 

*

 

Vanguard Target Retirement 2050 Trust I

 

Common Collective Trust

 

**

 

 

14,257

 

*

 

Vanguard Target Retirement 2055 Trust I

 

Common Collective Trust

 

**

 

 

2,101

 

*

 

Vanguard Target Retirement 2060 Trust I

 

Common Collective Trust

 

**

 

 

1,796

 

*

 

Vanguard Target Retirement Income Trust I

 

Common Collective Trust

 

**

 

 

18,348

 

*

 

Wellington Small Cap 2K

 

Common Collective Trust

 

**

 

 

21,276

 

*

 

Wellington Trust TIPS

 

Common Collective Trust

 

**

 

 

6,076

 

*

 

Notes Receivable from Participants

 

Loans/Interest rates from 4.25%

to 10%; maturities from

January 2015 to October 2044

 

**

 

 

24,129

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

*

 

Indicates party-in-interest to the Plan

 

**

 

Not applicable - Historical cost information is not required to be presented, as all investments are participant-directed.

 

 

 

 

 

 

 

 

 

 

 

 

 

9

 


 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Science Applications International Corporation Benefit Plans Committee has duly caused this annual report to be signed on its behalf by the undersigned hereunto duly authorized.

 

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION RETIREMENT PLAN

 

Date: June 26, 2015

 

 

/s/ Melinda H. McBee

 

 

 

Melinda H. McBee

 

 

 

Member, Science Applications International Corporation

 

 

 

Benefit Plans Committee

 

10

 


 

Exhibit Index

 

Exhibit No.

 

Description of Exhibit

23.1

 

Consent of Independent Registered Public Accounting Firm

 

 

11